The 8 analysts offering 12-month price forecasts for 10X Genomics Inc have a median target of 207.50, with a high estimate of 240.00 and a low estimate of 175.00. The median estimate represents a +33.06% increase from the last price of 155.94.
The current consensus among 8 polled investment analysts is to Buy stock in 10X Genomics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.28
Reporting Date May 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.